Epidemiology of multiple sclerosis in Europe: a review
- PMID: 20233110
- DOI: 10.3109/09540261003589216
Epidemiology of multiple sclerosis in Europe: a review
Abstract
Multiple sclerosis (MS) is a progressive demyelinating and degenerative disease of the CNS with symptoms dependent on the type of the disease and the site of lesions. During the progression of the disease, symptoms become more permanent and progressive disability ensues. MS is a disease characterized by wide variations between patients, thus making categorization difficult. The aim of the current study was to review the existing epidemiological data of MS in Europe published during the last decade (2000-2009), using PubMed. Findings revealed an increasing incidence of MS during the last decade. Recent data indicate that latitude does not play a key role in determining the onset of the disease. MS has a significant impact on the quality of life for most patients over many years. The disease is twice as common in women than in men, and is at its peak in the most economically productive years of life. Pregnancy, postpartum status and vaccines may influence the onset and the course of the disease. Only one of the reviewed papers provides a view of progression from onset to death.
Similar articles
-
Clustering of multiple sclerosis, age of onset and gender in Sardinia.J Neurol Sci. 2009 Nov 15;286(1-2):6-13. doi: 10.1016/j.jns.2009.07.013. Epub 2009 Aug 11. J Neurol Sci. 2009. PMID: 19674758
-
Possible increasing risk of multiple sclerosis in Catania, Sicily.Neurology. 2005 Oct 25;65(8):1259-63. doi: 10.1212/01.wnl.0000180628.38786.85. Neurology. 2005. PMID: 16247054
-
Epidemiology of multiple sclerosis in western Herzegovina.Clin Neurol Neurosurg. 2007 Nov;109(9):779-83. doi: 10.1016/j.clineuro.2007.07.014. Epub 2007 Sep 4. Clin Neurol Neurosurg. 2007. PMID: 17766036
-
Epidemiology and current treatment of multiple sclerosis in Europe today.J Rehabil Res Dev. 2002 Mar-Apr;39(2):175-85. J Rehabil Res Dev. 2002. PMID: 12051462 Review.
-
Genes, environment, and susceptibility to multiple sclerosis.Neurobiol Dis. 2004 Nov;17(2):131-43. doi: 10.1016/j.nbd.2004.07.015. Neurobiol Dis. 2004. PMID: 15474351 Review.
Cited by
-
Fingolimod for relapsing-remitting multiple sclerosis.Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD009371. doi: 10.1002/14651858.CD009371.pub2. Cochrane Database Syst Rev. 2016. PMID: 27091121 Free PMC article.
-
Pregnancy in multiple sclerosis: a questionnaire study.PLoS One. 2014 Jun 5;9(6):e99106. doi: 10.1371/journal.pone.0099106. eCollection 2014. PLoS One. 2014. PMID: 24901447 Free PMC article.
-
Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients.Noro Psikiyatr Ars. 2017 Mar;54(1):11-14. doi: 10.5152/npa.2016.12451. Epub 2017 Mar 1. Noro Psikiyatr Ars. 2017. PMID: 28566952 Free PMC article.
-
Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project.Pharmaceuticals (Basel). 2020 Dec 15;13(12):466. doi: 10.3390/ph13120466. Pharmaceuticals (Basel). 2020. PMID: 33333889 Free PMC article.
-
Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in Taiwan.PLoS One. 2013 Jun 17;8(6):e65911. doi: 10.1371/journal.pone.0065911. Print 2013. PLoS One. 2013. PMID: 23799061 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical